Biogen pulls application for Alzheimer's drug in Europe
The drugmaker said the move follows interactions with the European Medicines Agency that suggested data provided so far would not be enough to support an approval.
A sign marks a Biogen facility, some of whose employees have tested positive for the coronavirus after attending a meeting in Boston, in Cambridge, Massachusetts, US, March 9, 2020.(photo credit: REUTERS/BRIAN SNYDER/FILE PHOTO)ByREUTERS
